YEREVAN, October 9. / ARKA /. Vigen Topuzyan, the director of the Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of Armenia, urged today the government to revise the legislation governing production of medicines, because in its current form it contains inaccuracies and omissions that lead to serious problems in this area, after the economy ministry has banned it from production of medications due to lack of a Good Manufacturing Practice (GMP) certificate of conformity, introduced in Armenia earlier this year for pharmaceutical companies.
The ministry of economy I said to be inspecting local pharmaceutical companies in order to verify their compliance with GMP standards.
"Despite the fact that we produced quality products for many years, now we can not do so any longer, because we were not awarded the GMP certificate, although our products comply with its requirements,’ Topuzyan said at a news conference.
He said the ban was justified by the fact that the equipment used for drug production does not comply with the latest European standards.
In this context, Topuzyan noted that there are no specific standards and documents to be used to monitor the compliance of Armenian medications to European standards.
"I have repeatedly called on various government agencies to draw up a document in the Armenian language that will identify all the necessary standards for issuance of GMP certificate, but my requests remain unanswered ," he said.
Topuzyan also added that major Armenian medicines producing companies do not have GMP certificates either, however, they continue to work. ARKA has asked the health ministry for comments.
According to the National Statistical Service of Armenia, production of pharmaceutical products in January- August 2013 amounted to 3.315.3 billion drams, a 37 percent growth year-on-year.
The Scientific and Technological Center of Organic and Pharmaceutical Chemistry established in 2006 specializes in scientific research in the field of organic and pharmaceutical chemistry and production and sale of drugs and chemicals. ($1 – 405.75 drams). -0-